A new noninvasive test for kidney disease A new non-invasive test for kidney disease.

The test functions by identifying the amount of a cytokine molecule known as monocyte chemoattractant proteins-1 present in the urine. MCP-1 is definitely made by the physical body as a reply to inflammation, and attracts white bloodstream cells to the region to combat pathogens. However, overreaction of the white blood cells may cause vasculitis and organ harm also.. A new noninvasive test for kidney disease A new non-invasive test for kidney disease, developed by clinicians at Hammersmith Hospitals NHS Imperial and Trust College London, is providing a straightforward, safe, cheap and reliable approach to detecting kidney disease.The survivor is connected by The AACD with a local GBAS volunteer who provides treatment at no charge to the survivor. Making a Difference In July 2001, the AACD was one of only eight organizations in the world to get the Award of Excellence and the prestigious Associations Enhance America Summit Award because of its GBAS plan. The American Society of Association Executives , of Washington, D.C., sponsors this yearly national competition to identify the charitable organizations that make the most effort to advance American culture. Those interested in obtaining help with the Give Back A Smile plan should visit , call the National Hotline: 1.800.773.GBAS, or send an e-mail to Donations to the Give Back A Smile program can be made to the AACD Charitable Foundation, 5401 World Dairy Drive, Madison, Wisconsin 53718-3900.

3SBio enters into exclusive license with DiNonA for development of Leukotuximab 3SBio Inc., a respected China-based biotechnology company focused on researching, developing, marketing and manufacturing biopharmaceutical items, today announced it provides entered into an exclusive license with DiNonA Inc.